Bibliothek

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • Lead in blood  (2)
  • Regression  (1)
  • 1
    Digitale Medien
    Digitale Medien
    Springer
    International archives of occupational and environmental health 37 (1976), S. 89-105 
    ISSN: 1432-1246
    Schlagwort(e): Lead ; Lead in blood ; Protoporphyrin in erythrocytes ; Erythrocyte ALAD ; Urinary ALA ; Urinary coproporphyrin ; Correlation ; Regression ; Validity
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Summary In previous research we established that FEP is a suitable and valid test for evaluating the metabolic damage caused by lead absorption. In this study, in the same sample consisting of adult male subjects with PbB levels ranging from 15 to 150 μg/100 ml, we examined the relationship existing between PbB and the other indicators of effect so as to compare their behavior with that of FEP and establish whether there is a field of application where the erythrocyte metabolite is to be preferred. FEP and ALAD displayed a very much better correlation with PbB than the urinary tests (ALAU and CPU). The decrease in ALAD values is already clear at PbB levels which do not cause an elevation of FEP; on the other hand, when the enzyme is markedly inhibited, the erythrocyte metabolite is elevated further with the increase in the internal lead load. FEP increases earlier compared to ALAU and CPU; nevertheless, the urinary metabolites undergo increasing elevations at PbB levels higher than 90 μg/100 ml when the FEP values have become stable. We confirmed that FEP possesses good predictive validity at PbB levels of 60 and 70 μg/100 ml; for such PbB levels, also ALAD, measured with the European Standardized Method, displayed high validity. Validity of the urinary metabolites was rather modest. FEP was, moreover, well correlated also with other indicators, suggesting that the erythrocyte metabolite may be used to predict both dose and effect.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    Digitale Medien
    Digitale Medien
    Springer
    International archives of occupational and environmental health 44 (1979), S. 127-132 
    ISSN: 1432-1246
    Schlagwort(e): Chelatable lead ; Lead in blood ; Lead in urine
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Summary Chelatable lead (PbU-EDTA) is the best indicator of lead concentration at the critical organ level (indicator of dose). However, since this test is not easily applicable for the biological monitoring of lead-exposed subjects, the current practice is to determine lead in blood (PbB) and/or in urine (PbU). But these tests are indicators of exposure and not of dose. To analyze the reliability of PbB and PbU in estimating lead dose, the relationships between PbU-EDTA and PbB and between PbU-EDTA and PbU were studied in two groups of male lead workers: 48 currently exposed and 45 with past exposure to lead. In currently exposed workers the correlation between PbU-EDTA and PbB and between PbU-EDTA and PbU was very close (r = 0.85, r = 0.74, respectively); in past exposed workers the correlation with PbU-EDTA was decidedly lower for PbB (r = 0.54) and not significant for PbU (r = 0.29). In both cases the relationship between the variables was linear. In the previously exposed men, PbB displayed lower values than those found in currently exposed men. These results indicate that both PbB and PbU allow an indirect estimation to be made of the internal dose in currently exposed subjects, whereas the tests cannot be used for this purpose in subjects who have long since ceased to be exposed. In these cases chelatable lead must be determined.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...